1. Introduction {#s0005}
===============

Cerebrotendinous xanthomatosis is a lipid storage disease characterized by diarrhea, cataract, tendon xanthoma and neurological dysfunction. The onset of these features follows a chronological order. *CYP27A1* is the only gene in which mutations are known to cause Cerebrotendinous xanthomatosis. *CYP27A1* gene is located in chromosome 2q33 and contains nine exons. This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Early diagnosis by biochemical testing or molecular genetic testing if the two disease-causing mutations in the family are known allows for early treatment that may prevent or limit disease manifestations. Cerebrotendinous xanthomatosis is inherited in an autosomal recessive manner. To date around 90% of cases of Cerebrotendinous xanthomatosis have been ascribed to point mutations and another 8% to deletions or duplications [@bb0005].

2. Material and methods {#s0010}
=======================

Two Indian families (family 1 and family 2) with a clinical diagnosis of Cerebrotendinous xanthomatosis were recruited for CYP27A1 gene analysis after obtaining informed consent. The clinical, laboratory and radiological characteristics are summarized in [Table 1](#t0005){ref-type="table"}.

The study was funded by Christian Medical College, Vellore fluid research grant (IRB No. 8491/9-10-13). The study was approved by the Institutional Review Board and the Ethics Committee and 5 ml of blood was collected aseptically from the affected patients, parents, (father of affected family 1 was unavailable) and unaffected siblings. DNA was extracted with QIAamp DNA Minikit from Qiagen as per standard protocol. DNA purity was checked in a Nanodrop instrument. PCR of all exons and intron--exon boundaries was done using a published protocol [@bb0010]. PCR products were visualized by electrophoresis in 2% agarose gel. PCR products were purified using Exosap kit from Qiagen. PCR products were sequenced by Sanger sequencing in ABI 3500 genetic analyzer. Sequences were analyzed in Ensemble database and pathogenic mutations were checked in Human Genome Mutation Database (public version) for previous reports on 02.09.2014.

3. Results {#s0015}
==========

The genotyping results are summarized in [Table 2](#t0010){ref-type="table"}. Two affected individuals from the first family had a homozygous c.526delG mutation and the mother is a heterozygote --- [Fig. 1](#f0005){ref-type="fig"}.

This is a known pathogenic mutation which leads to frame shift. The single affected individual from the second family had a homozygous c.446 + 1G-A mutation. This is also a known splice donor site mutation. Parents are heterozygotes --- [Fig. 2](#f0010){ref-type="fig"}.

4. Discussion {#s0020}
=============

We describe two different mutations in the CTX patients belonging to two different regions of India. The first familial case from Eastern India has homozygous c.526delG.mutation, the affected sister is homozygous while the mother who is unaffected is heterozygous for this known mutation. The father was unavailable for testing and is presumed to be a carrier. The second case and the first one to be reported from South India have homozygous c.446 + 1G-A mutation which is already reported in heterozygous state in a Spanish patient [@bb0015]. The parents are heterozygous for the mutation. Previously our laboratory has reported the first Indian case with the same homozygous c.526delG mutation also from Eastern India [@bb0020]. Another report from the Northern part of the Country described a patient with compound heterozygous (c. 1151C \> T p. P384L and c. 2T \> C p.M1T) [@bb0025]. Patients from all three regions have separate mutations. However to date two unrelated Eastern Indian families have the same homozygous c.526delG mutation. The only documented report of the same mutation was from the Netherlands in a Surinamese patient [@bb0030]. The pathogenic mutations in Cerebrotendinous xanthomatosis are usually restricted to specific populations except for R362C mutation which has been reported from the Netherlands and the USA (Black) [@bb0035]. The present reported mutation is the second of its kind to be reported from two different populations. As human trading between Eastern India and Surinam was prevalent in the ninetieth century this mutation might represent a common founder mutation [@bb0040].
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###### 

Clinical details of the probands in two families studied.

  Patient                                 Family I-A                                                             Family II-C                                                                                                               
  --------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------- ----
  Ethnicity                               Eastern India                                                          Southern India                                                                                                            
  Consanguinity                           No                                                                     Yes (3rd degree)                                                                                                          
  Age (in years)/sex                      26/male                                                                33/male                                                                                                                   
  Age at onset of first symptom (years)   4 (diarrhea)                                                           7 (prolonged cholestatic jaundice)                                                                                        
  Age at diagnosis (years)                25                                                                     32                                                                                                                        
  Age at onset of symptoms (years)        Diarrhea                                                               04                                                                                                                        08
  Xanthomas                               10                                                                     30                                                                                                                        
  Cataract                                14                                                                     27                                                                                                                        
  Neurological symptoms                   24                                                                     30                                                                                                                        
  Seizures                                −                                                                      \+                                                                                                                        
  Jaundice                                −                                                                      \+                                                                                                                        
  Intellectual disability                 \+                                                                     \+                                                                                                                        
  Palatal myoclonus                       −                                                                      \+                                                                                                                        
  Pes cavus                               \+                                                                     \+                                                                                                                        
  Spasticity                              \+                                                                     \+                                                                                                                        
  Cerebellar signs                        \+                                                                     \+                                                                                                                        
  Bulbar involvement                      −                                                                      \+                                                                                                                        
  Gall stones                             −                                                                      −                                                                                                                         
  Infertility                             −                                                                      \+                                                                                                                        
  Cholesterol levels (mg/dl)              129                                                                    133                                                                                                                       
  MRI brain                               Periventricular white matter hyperintensity, mild cerebellar atrophy   Symmetric hyperintensity along CST with marked cerebellar and cerebral atrophic changes, dentate nucleus hyperintensity   
  Nerve conduction study                  Motor demyelinating polyneuropathy                                     Motor demyelinating polyneuropathy                                                                                        
  Somatosensory evoked potential          ND                                                                     Cortical potentials not obtained                                                                                          
  Visual evoked potential                 ND                                                                     Bilateral anterior optic pathway dysfunction                                                                              
  Cardiac workup                          Left ventricular hypertrophy                                           Normal                                                                                                                    

(ND --- not done, + present, − absent, CST --- corticospinal tract).

###### 

CYP27A1 gene analysis results.

  Family   Case   Mutation                         Exon/intron                  Position           Consequences                  Result       Previous reports
  -------- ------ -------------------------------- ---------------------------- ------------------ ----------------------------- ------------ ------------------------------------------------------
  1        A, B   Homozygous deletion of G         Exon 3                       c.526delG          Frame shift                   Pathogenic   Verrips et al. 1996; Shah et al., 2012
  2        C      Homozygous G to A substitution   Intron 2 splice donor site   c.446 + 1 G to A   Splice donor site variation   Pathogenic   Verrips et al. 2000 (in compound heterozygous state)
